Allendale Pharma's Today Sponge Labeling Passes FDA Panel Muster
This article was originally published in The Gray Sheet
Executive Summary
Proposed labeling for Allendale Pharmaceuticals' Today sponge adequately conveys the risks associated with use of the female contraceptive albeit with some minor adjustments, FDA's Nonprescription Drugs Advisory Committee concluded at a July 12 meeting.
You may also be interested in...
Spongeworthy
Allendale Pharmaceuticals recommences sales of the Today Sponge via two Canadian Internet sites. FDA approval is expected within a year after being off the market since 1995 due to quality control systems issues (1"The Gray Sheet" July 17, 2000, p. 11)...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.